Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27937922 | 0.83 | TP53 (0.35) | TP53 | |
| SCHEMBL17677157 | 0.78 | TP53 (0.35) | TP53 | |
| SCHEMBL993289 | 0.75 | — | — | |
| SCHEMBL28119925 | 0.74 | — | — | |
| SCHEMBL1939465 | 0.74 | TSHR (0.46) | MEN1GLACYP2C19KMT2A | |
| Water SCHEMBL8187043 | 0.73 | — | — | |
| SCHEMBL1133057 | 0.73 | — | — | |
| SCHEMBL5180984 | 0.73 | — | — | |
| SCHEMBL3160885 | 0.73 | — | — | |
| SCHEMBL2805351 | 0.72 | TP53 (0.30) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105263895-B | For purification of acetic acid and acrylic acid | 沙特基础工业公司 | 2018-04-10 | — | — | CN | claimed |
| CN-107365101-A | Water-based emulsion based on propyl group Ethoxysilane oligomer is used for the purposes for reducing Shrinkage behavior in cement admixture | 赢创德固赛有限公司 | 2017-11-21 | — | — | CN | claimed |
| CN-104937493-B | Composition for forming resist upper layer film for lithography and method for manufacturing semiconductor device | 日产化学工业株式会社 | 2019-11-08 | — | — | CN | disclosed |
| CN-106795179-B | Kinase inhibitor | 锦州奥鸿药业有限责任公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-110178204-A | Cleaning agent for semiconductor substrate | 株式会社大赛璐 | 2019-08-27 | — | — | CN | disclosed |
| CN-105694589-B | Non-aqueous inkjet printing ink composition | 精工爱普生株式会社 | 2019-07-16 | — | — | CN | disclosed |
| CN-105794029-B | Binder for electrochemical cell, paste for electrochemical cell, and method for producing electrode for electrochemical cell | 三井化学株式会社 | 2019-07-12 | — | — | CN | disclosed |
| CN-109462980-A | Combination of LSD1 inhibitors for the treatment of hematologic malignancies | 奥莱松基因组股份有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-108530480-A | GPR84 receptor antagonists and its application | 中国科学院上海药物研究所 | 2018-09-14 | — | — | CN | disclosed |
| CN-108504094-A | Polyimide precursor solution and polyimide film | 富士施乐株式会社 | 2018-09-07 | — | — | CN | disclosed |
| CN-108454253-A | Recording method and recording device | 精工爱普生株式会社 | 2018-08-28 | — | — | CN | disclosed |
| CN-103608906-B | Method for manufacturing amorphous oxide thin film and thin film transistor | 富士胶片株式会社 | 2016-11-09 | — | — | CN | disclosed |
| CN-104478821-B | Oxadiazole diaryl compounds | 默克雪兰诺有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-104147011-A | Uses of pyridine-diketone serving as PDE4 inhibitor for treating eye diseases | ASTRAZENECA AB | 2014-11-19 | — | — | CN | disclosed |
| EP-2513069-B1 | ANTIFUNGAL COMPOUNDS | UNIV LEUVEN KATH (BE) | 2014-10-15 | — | — | EP | disclosed |
| EP-2513069-A1 | ANTIFUNGAL COMPOUNDS | Katholieke Universiteit Leuven (BE) | 2012-10-24 | — | — | EP | disclosed |
| US-20120252801-A1 | ANTIFUNGAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2012-10-04 | — | — | US | disclosed |
| WO-2011072345-A1 | ANTIFUNGAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2011-06-23 | — | — | WO | disclosed |
| CN-101437513-A | Use of imidazo [2, 1-b ] -1, 3, 4-thiadiazole-2-sulfonamide compounds for the treatment of neuropathic pain | AEGERA THERAPEUTICS INC (CA) | 2009-05-20 | — | — | CN | disclosed |
| US-6506393-B2 | Administering phosphocholine compound; leishmaniasis treatment | ZENTARIS AG (DE) | 2003-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252801-A1 | ANTIFUNGAL COMPOUNDS | ERG28, DPM1, CYP51A1 | TP53 2714/4885MEN1 447/4885GLA 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.